# IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).

> **NCT03718273** · PHASE3 · COMPLETED · sponsor: **Adolfo Fontenla** · enrollment: 68 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Diseases

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT03718273
- **Lead sponsor:** Adolfo Fontenla
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-19
- **Primary completion:** 2022-02-22
- **Final completion:** 2022-06-30
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-10-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03718273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03718273, "IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03718273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*